- Joined
- Dec 3, 2017
- Messages
- 26,290
- Reaction score
- 16,771
- Gender
- Male
- Political Leaning
- Progressive
After 4-year delay, DEA will review dozens of requests to grow marijuana for research | Science | AAAS
In certain states, growing marijuana is allowed, but only one source nationally is legal for researchers. That could change with new rules from the Drug Enforcement Administration.
After 4-year delay, DEA will review dozens of requests to grow marijuana for research
After nearly 4 years of what some researchers saw as foot dragging, the Drug Enforcement Administration (DEA) has announced it will evaluate 37 applications to grow marijuana for medical research and proposed new rules for the prospective growers that outline how the cannabis-growing program would work.
“The release of this framework is absolutely monumental and is the biggest, the most meaningful, and material progress made in federal cannabis policy in decades,” says George Hodgin, CEO of the Biopharmaceutical Research Company, one of the applicants. “It opens up a path for traditional drug development in the United States,” whereby researchers can conduct clinical trials and seek approval from the Food and Drug Administration (FDA) for marijuana-based therapies.
===============================================
MJ has been used for thousands of years. It has a lot of promise in the development of new pharmaceuticals.
In certain states, growing marijuana is allowed, but only one source nationally is legal for researchers. That could change with new rules from the Drug Enforcement Administration.
After 4-year delay, DEA will review dozens of requests to grow marijuana for research
After nearly 4 years of what some researchers saw as foot dragging, the Drug Enforcement Administration (DEA) has announced it will evaluate 37 applications to grow marijuana for medical research and proposed new rules for the prospective growers that outline how the cannabis-growing program would work.
“The release of this framework is absolutely monumental and is the biggest, the most meaningful, and material progress made in federal cannabis policy in decades,” says George Hodgin, CEO of the Biopharmaceutical Research Company, one of the applicants. “It opens up a path for traditional drug development in the United States,” whereby researchers can conduct clinical trials and seek approval from the Food and Drug Administration (FDA) for marijuana-based therapies.
===============================================
MJ has been used for thousands of years. It has a lot of promise in the development of new pharmaceuticals.
